Skip to main content
OpenTrials
Completed

NCT Number: NCT02096523

Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder

The goal of this study is to identify the platelet defect responsible for the bleeding in families from our inherited platelet disorders Israeli-Palestinian registry. The investigators plan to characterize platelet proteome expression after removing high abundance proteins. The investigators will compare the proteome of sick and healthy members of families with inherited platelet disorders, and identify and validate structural proteins, signaling cascades and biomarkers for detection and diagnosis of unknown platelet disorders. The investigators expect to discover new key findings that allow better understanding of human platelet function and allow better diagnosis and treatment of patients with inherited platelet function disorders.

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hadassah Medical Organization

Jerusalem, Israel

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • History of inherited platelet disorders in the family

Exclusion criteria

  • none

Treatment and study plan

Blood collection for platelet protein samples

Other

Primary outcomes

  1. Levels of detectable platelet proteins

    Time frame: 2014-2015 (1 year)

    Characterize platelet proteome expression profile

Secondary outcomes

  1. Changes in protein expression from sick and healthy platelets

    Time frame: 2015-2019 (4 years)

    Analysis of platelet proteome of sick and healthy members of families with inherited platelet disorders

Other outcomes

  1. Number of proteins that inducate disease

    Time frame: 2017-2019 (2 years)

    Identify and validate a panel of specific biomarkers candidates

Sponsors and collaborators

Lead sponsor

Ela Shai

Other

Registry information

Important dates

Study start
2016
Primary completion
2021
Study completion
2021
First posted
Mar 26, 2014
Registry last updated
Aug 25, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.